• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于体外检测伯氏疏螺旋体对抗菌物质敏感性的新型比色微量稀释法。

New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.

作者信息

Hunfeld K P, Kraiczy P, Wichelhaus T A, Schäfer V, Brade V

机构信息

Institute of Medical Microbiology, University Hospital of Frankfurt, Frankfurt/Main, Germany.

出版信息

Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):27-32. doi: 10.1007/s100960050005.

DOI:10.1007/s100960050005
PMID:10706176
Abstract

A newly developed colorimetric microdilution method was used to analyze the activity of 12 antimicrobial agents against nine Borrelia burgdorferi isolates, including all three genospecies pathogenic for humans. In addition, in vitro antimicrobial resistance patterns of Borrelia valaisiana and Borrelia bissettii tick isolates were investigated. The applied test system is based upon color changes that occur in the presence of phenol red and result from the accumulation of nonvolatile acid produced by actively metabolizing spirochetes. After 72 h of incubation, minimal inhibitory concentrations (MICs) were determined from the decrease of absorbance by software-assisted calculation of growth curves. MIC values were lowest for azlocillin (MIC, < or = 0.125 microg/ml), ceftriaxone (MIC range, < or = 0.015-0.06 microg/ ml), and azithromycin (MIC range, < or = 0.015-0.06 microg/ml). Whereas tobramycin (MIC range, 8-64 microg/ml) exhibited little activity, spectinomycin (MIC range, 0.25-2 microg/ml) showed in vitro antimicrobial activity against Borrelia burgdorferi. The MICs of penicillin G for Borrelia afzelii isolates were ten times higher than those for Borrelia burgdorferi, Borrelia valaisiana, and Borrelia bissettii isolates (P<0.05) and 100 times higher than those for isolates belonging to the genospecies Borrelia garinii (P < 0.05). Further significant differences with respect to the MIC values of the other antimicrobial agents tested were not noted. The colorimetric microdilution method offered the advantages of reliability, reproducibility, and convenience and could handle large numbers of isolates and antibiotics.

摘要

一种新开发的比色微量稀释法被用于分析12种抗菌剂对9株伯氏疏螺旋体分离株的活性,其中包括对人类致病的所有三种基因型。此外,还研究了瑞士疏螺旋体和比氏疏螺旋体蜱分离株的体外抗菌耐药模式。所应用的测试系统基于在酚红存在下发生的颜色变化,这种变化是由活跃代谢的螺旋体产生的非挥发性酸的积累引起的。孵育72小时后,通过软件辅助计算生长曲线,根据吸光度的降低来确定最低抑菌浓度(MIC)。阿洛西林的MIC值最低(MIC,≤0.125微克/毫升),头孢曲松的MIC范围为≤0.015 - 0.06微克/毫升,阿奇霉素的MIC范围为≤0.015 - 0.06微克/毫升。而妥布霉素(MIC范围为8 - 64微克/毫升)活性很小,壮观霉素(MIC范围为0.25 - 2微克/毫升)显示出对伯氏疏螺旋体的体外抗菌活性。青霉素G对阿氏疏螺旋体分离株的MIC值比对伯氏疏螺旋体、瑞士疏螺旋体和比氏疏螺旋体分离株高10倍(P<0.05),比对伽氏疏螺旋体基因型分离株高100倍(P < 0.05)。未发现与所测试的其他抗菌剂的MIC值有进一步的显著差异。比色微量稀释法具有可靠性、可重复性和便利性的优点,并且可以处理大量的分离株和抗生素。

相似文献

1
New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.用于体外检测伯氏疏螺旋体对抗菌物质敏感性的新型比色微量稀释法。
Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):27-32. doi: 10.1007/s100960050005.
2
Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.青霉素、头孢菌素、大环内酯类、链阳菌素、四环素和氨基糖苷类对伯氏疏螺旋体分离株的比色法体外药敏试验。
Int J Antimicrob Agents. 2000 Jun;15(1):11-7. doi: 10.1016/s0924-8579(00)00116-3.
3
In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.氟喹诺酮类药物对疏螺旋体伯氏疏螺旋体的体外活性。
Antimicrob Agents Chemother. 2001 Sep;45(9):2486-94. doi: 10.1128/AAC.45.9.2486-2494.2001.
4
In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.四种抗生素对伯氏疏螺旋体的体外药敏试验:伯氏疏螺旋体狭义种、阿氏疏螺旋体和伽氏疏螺旋体三种基因种结果的比较
J Clin Microbiol. 2003 Apr;41(4):1791-3. doi: 10.1128/JCM.41.4.1791-1793.2003.
5
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.伯氏疏螺旋体的体外抗菌药敏试验:微量稀释法测定最低抑菌浓度及时间杀菌研究
J Clin Microbiol. 1992 Oct;30(10):2692-7. doi: 10.1128/jcm.30.10.2692-2697.1992.
6
In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.来自不同来源的30株疏螺旋体菌株对8种抗微生物化疗药物的体外敏感性。
Infection. 1996 Jan-Feb;24(1):60-3. doi: 10.1007/BF01780660.
7
In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.伯氏疏螺旋体分离株对三种常用于治疗马莱姆病的抗生素的体外敏感性。
BMC Vet Res. 2017 Sep 29;13(1):293. doi: 10.1186/s12917-017-1212-3.
8
Susceptibility of Borrelia afzelii strains to antimicrobial agents.阿氏疏螺旋体菌株对抗菌药物的敏感性。
Int J Antimicrob Agents. 2005 Jun;25(6):474-8. doi: 10.1016/j.ijantimicag.2005.02.007.
9
In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.对来自游走性红斑患者的伯氏疏螺旋体狭义种分离株在抗菌化疗前后进行体外药敏试验。
Antimicrob Agents Chemother. 2005 Apr;49(4):1294-301. doi: 10.1128/AAC.49.4.1294-1301.2005.
10
In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.美洛西林、美罗培南、氨曲南、万古霉素、替考拉宁、核糖霉素和夫西地酸对伯氏疏螺旋体的体外活性。
Int J Antimicrob Agents. 2001 Mar;17(3):203-8. doi: 10.1016/s0924-8579(00)00342-3.

引用本文的文献

1
Genomic characterization and antibiotic susceptibility of biofilm-forming and from patients with erythema migrans.来自游走性红斑患者的生物膜形成细菌的基因组特征及抗生素敏感性
Front Cell Infect Microbiol. 2025 Jul 7;15:1619660. doi: 10.3389/fcimb.2025.1619660. eCollection 2025.
2
Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis.缩短莱姆病抗生素治疗疗程的研究:一项系统评价与荟萃分析
Infection. 2025 Apr 17. doi: 10.1007/s15010-025-02501-3.
3
The In Vitro Antimicrobial Susceptibility of sensu lato: Shedding Light on the Known Unknowns.
广义的体外抗菌药敏性:揭示已知的未知因素。
Pathogens. 2023 Sep 28;12(10):1204. doi: 10.3390/pathogens12101204.
4
Antimicrobial Peptide Mastoparan-AF Kills Multi-Antibiotic Resistant O157:H7 via Multiple Membrane Disruption Patterns and Likely by Adopting 3-11 Amphipathic Helices to Favor Membrane Interaction.抗菌肽马斯托帕兰-AF通过多种膜破坏模式杀死多重耐药O157:H7,可能是通过采用3-11两亲性螺旋来促进与膜的相互作用。
Membranes (Basel). 2023 Feb 20;13(2):251. doi: 10.3390/membranes13020251.
5
The Diadenylate Cyclase CdaA Is Critical for Borrelia turicatae Virulence and Physiology.环二核苷酸磷酸二酯酶 CdaA 对土耳其包柔螺旋体的毒力和生理功能至关重要。
Infect Immun. 2021 May 17;89(6). doi: 10.1128/IAI.00787-20.
6
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.阿洛西林可能成为对抗耐多药伯氏疏螺旋体 JLB31 的潜在候选药物。
Sci Rep. 2020 Mar 2;10(1):3798. doi: 10.1038/s41598-020-59600-4.
7
Antimicrobial Resistance in , , and Other Rarely Investigated Veterinary and Zoonotic Pathogens.兽医和人畜共患病罕见病原体中的抗微生物药物耐药性。
Microbiol Spectr. 2018 Jul;6(4). doi: 10.1128/microbiolspec.ARBA-0029-2017.
8
Antimicrobial Susceptibility of Clinical Isolates of Borrelia miyamotoi.伯氏疏螺旋体临床分离株的抗菌药敏性
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00419-18. Print 2018 Jul.
9
Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.伯氏疏螺旋体对抗菌药物的敏感性。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00535-17. Print 2017 Sep.
10
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.莱姆病的病原体伯氏疏螺旋体可形成耐药性持留菌。
Antimicrob Agents Chemother. 2015 Aug;59(8):4616-24. doi: 10.1128/AAC.00864-15. Epub 2015 May 26.